Dr. Ragnar
Risperdal Consta
Risperdal Consta is older long-acting risperidone technology. It can help with adherence, but the two-week overlap and side effects matter.
Feb 26, 2026
Invega Sustenna
Invega Sustenna is a long-acting injectable built for adherence, relapse prevention, and patients who do better without daily pill logistics.
Feb 23, 2026
Aristada (aripiprazole lauroxil)
Aristada is long-acting aripiprazole. The point is not a new effect so much as steadier delivery and fewer missed-dose failures.
Feb 20, 2026
Abilify Maintena
Abilify Maintena turns oral aripiprazole into a monthly adherence tool. The question is whether that solves the real problem.
Feb 18, 2026
Armodafinil (Nuvigil)
Armodafinil is one of those drugs that lives in two different stories at once. In the boring real clinical story, it’s a wakefulness medication for excessive sleepiness in…
Feb 15, 2026
Azstarys
Azstarys is a two-speed dexmethylphenidate stimulant: one part starts fast, while the prodrug portion stretches the day.
Feb 13, 2026
Evekeo
Evekeo is plain amphetamine sulfate. It is older stimulant chemistry without the complicated release systems or marketing language.
Feb 10, 2026
Jornay PM
Jornay PM is an unusual ADHD stimulant because it is taken at night so it can start helping the next morning.
Feb 7, 2026
Daytrana
Daytrana is methylphenidate delivered through a skin patch, useful when swallowing pills or controlling duration is the problem.
Feb 5, 2026
Qelbree (viloxazine)
Qelbree is a nonstimulant ADHD medication, which makes it useful for some patients and overmarketed for others.
Feb 2, 2026
Mydayis
Mydayis is an Adderall XR relative built to release later into the day, which some adults love and others feel lasts too long.
Jan 30, 2026
Dexedrine (dextroamphetamine)
Dexedrine is classic dextroamphetamine: effective, direct, and deserving of both its clinical respect and its cautions.
Jan 28, 2026